{"id":29619,"date":"2023-08-09T10:49:42","date_gmt":"2023-08-09T14:49:42","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=29619"},"modified":"2023-08-14T14:51:23","modified_gmt":"2023-08-14T18:51:23","slug":"vivek-verma-phd","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/vivek-verma-phd","title":{"rendered":"Vivek Verma, PhD"},"content":{"rendered":"\n<p>To enhance mitochondrial fitness and prevent T cell exhaustion, Dr. Verma intends to explore the possibility of targeting pyruvate kinase (PK)M2, an enzyme involved intricately in regulating metabolism and gene expression in CD8 T cells. Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Melanoma is one of the most aggressive and deadly skin cancers. Immunotherapy using immune checkpoint blocking (ICB) antibodies such as anti-PD1 and anti-CTLA4 is a promising therapeutic strategy for patients with advanced melanoma. However, even in the optimal scenarios with combination ICB therapy, approximately half of patients do not respond to the therapy. Activating immune cells is a critical factor that decides therapeutic outcomes.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Mitochondria are an integral part of cellular energy machinery that play significant roles in the activation, proliferation, differentiation, and effector functions of immune cells. Impaired mitochondrial functions are associated with diminished activation and increased exhaustion in T cells. Tumor-infiltrating lymphocytes (TILs) show repressed mitochondrial metabolism and decreased mitochondrial mass that renders TILs exhausted and ineffective in curing cancer. Organization of mitochondrial inner membrane structures called cristae seem to be extremely important for mitochondria to optimally function. &nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><strong><strong><strong><strong><strong>Targeting T cell exhaustion via mitochondrial reorganization for enhanced immunotherapy of melanoma <\/strong><\/strong> <\/strong><\/strong><\/strong>&nbsp;<\/strong><\/h3>\n\n\n\n<p>University of Minnesota | Melanoma | 2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>To enhance mitochondrial fitness and prevent T cell exhaustion, Dr. Verma intends to explore the possibility of targeting pyruvate kinase (PK)M2, an enzyme involved intricately in regulating metabolism and gene expression in [&hellip;]<\/p>\n","protected":false},"featured_media":29620,"template":"","tax_cancer_type":[354],"tax_grant_type":[485],"tax_award_year":[480],"tax_institutions":[586],"tax_location_states":[532],"class_list":["post-29619","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI CLIP Investigator","quote":"","scientist_last_name":"Verma","show_on_landing":true,"scientist_publish_until":"20260731"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vivek Verma, PhD<\/title>\n<meta name=\"description\" content=\"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vivek Verma, PhD\" \/>\n<meta property=\"og:description\" content=\"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-14T18:51:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"585\" \/>\n\t<meta property=\"og:image:height\" content=\"740\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd\",\"url\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd\",\"name\":\"Vivek Verma, PhD\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg\",\"datePublished\":\"2023-08-09T14:49:42+00:00\",\"dateModified\":\"2023-08-14T18:51:23+00:00\",\"description\":\"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg\",\"width\":585,\"height\":740,\"caption\":\"Vivek Verma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vivek Verma, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vivek Verma, PhD","description":"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd","og_locale":"es_ES","og_type":"article","og_title":"Vivek Verma, PhD","og_description":"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd","og_site_name":"Cancer Research Institute","article_modified_time":"2023-08-14T18:51:23+00:00","og_image":[{"width":585,"height":740,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd","name":"Vivek Verma, PhD","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg","datePublished":"2023-08-09T14:49:42+00:00","dateModified":"2023-08-14T18:51:23+00:00","description":"Through this research, Dr. Verma anticipates developing a clinically relevant target that can be utilized for enhancing metabolic fitness, preventing immune cell exhaustion, and reversing resistance to immune therapy.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg","width":585,"height":740,"caption":"Vivek Verma"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/vivek-verma-phd#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Vivek Verma, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/08\/Verma-Vivek.jpg","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/29619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/29620"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=29619"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=29619"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=29619"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=29619"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=29619"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=29619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}